RGN and cardiac hypertrophy: There is no significant difference in the cardiac function between WT mice and SMP30 KO mice, however; we have recently reported that SMP30 plays a protective role in angiotensin II-induced cardiac hypertrophy and doxorubicin-induced cardiotoxicity in mice via anti-apoptosis and anti-oxidant effects [17,24,25].